It is a healthcare private not for profit company based in Hyderabad, Telangana, India, established in 2011.
2011 | Hyderabad, Telangana, India | ActiveCure Thalassemia, a active private not for profit company, was established on 21 July 2011 in Hyderabad, Telangana, India. Engaging in other hospital and medical care activities within the healthcare sector, it holds CIN: U85100TG2011NPL075631. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Mahesh Kumar Agarwal (Director), Chandrakant Agrawal (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 21-1-686, Rikab Gunj, Hyderabad, Telangana, 500002.
U85100TG2011NPL075631
075631
21 July 2011
₹0.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Cure Thalassemia — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahesh Kumar Agarwal | Director | 21 Jul 2011 | Current |
| Chandrakant Agrawal | Director | 21 Jul 2011 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cure Thalassemia, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2017, Cure Thalassemia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cure Thalassemia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cure Thalassemia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Thalassemia's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Cure Thalassemia last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Cure Thalassemia has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Mahesh Kumar Agarwal was appointed as a Director was appointed as a Director on 21 Jul 2011 & has been associated with this company since 14 years 4 months . was completed.
Chandrakant Agrawal was appointed as a Director was appointed as a Director on 21 Jul 2011 & has been associated with this company since 14 years 4 months . was recorded as a recent event.
Progress on Cure Thalassemia was registered on 21 Jul 2011 with Roc Hyderabad & aged 14 years 4 months as per MCA records. was documented.
The CIN of Cure Thalassemia is U85100TG2011NPL075631.
Cure Thalassemia is headquartered at 21-1-686, Rikab Gunj, Hyderabad, Telangana, 500002.
Cure Thalassemia was incorporated on 21 July 2011.
The current directors of Cure Thalassemia are
The primary industry of Cure Thalassemia is Healthcare.
Cure Thalassemia is unlisted.
The authorized capital of Cure Thalassemia is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Cure Thalassemia is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX